Drone-Based Drug Smuggling Jumps Over 10,000% In 5 Years, Clandestine Drug Labs Triple: NCB Data
Drone-based drug smuggling along the India-Pakistan border has registered an extraordinary surge, with cases increasing from just three in 2021 to 305 in 2025, a rise of approximately 10,067 per cent in five years. Punja
Ni Ankur Sharma··131K nabasa
Drone-Based Drug Smuggling Jumps Over 10,000% In 5 Years, Clandestine Drug Labs Triple: NCB Data
Drone-based drug smuggling along the India-Pakistan border has registered an extraordinary surge, with cases increasing from just three in 2021 to 305 in 2025, a rise of approximately 10,067 per cent in five years. Punjab accounted for 298 of these cases, emerging as the principal hotspot for drone-assisted drug trafficking in the country.
Officials claim that the activities are from traced drones and actual movements are much higher at the border.
The Narcotics Control Bureau’s (NCB) Annual Report 2025 also highlights a sharp increase in clandestine drug manufacturing, with enforcement agencies dismantling 30 illegal drug laboratories in 2025, compared with nine in 2021. The report identifies Maharashtra, Rajasthan and Madhya Pradesh as important centres of clandestine laboratory activity.
The findings point towards two significant developments in India’s narcotics landscape: the increasing use of unmanned aerial vehicles for cross-border smuggling and the expansion or improved detection of domestic synthetic-drug manufacturing networks.
Punjab’s Overwhelming Majority
The data says drone-based trafficking has emerged as a major and rapidly escalating threat along the India-Pakistan border.
The number of detected incidents increased from three in 2021 to 35 in 2022, before declining to 28 in 2023. The trend changed sharply thereafter, with cases rising to 179 in 2024 and 305 in 2025. This represents an approximately 70 per cent increase in cases over the previous year and more than a 100-fold increase compared with 2021.
The quantity of drugs seized through drone interceptions also increased substantially, from 10 kg in 2021 to 468 kg in 2025, registering a 98 per cent rise over 2024.
Punjab accounted for 298 of the 305 cases and 461 kg of the total 468 kg seized in 2025. Of the drugs seized in Punjab, heroin accounted for 449.751 kg, while methamphetamine accounted for 9.018 kg. Additional incidents were reported in Rajasthan and Jammu and Kashmir.
The concentration of cases in Punjab underlines the growing challenge faced by enforcement agencies along the western border, where trafficking networks are increasingly using unmanned aerial vehicles to circumvent conventional border controls.
Clandestine Drug Laboratories Triple
The second major concern highlighted in the report is the sharp increase in clandestine drug-manufacturing facilities.
NCB Annual Report data says enforcement agencies dismantled 30 clandestine drug laboratories in 2025, exceeding the combined number detected during the previous three years.
The year-wise figures show nine laboratories dismantled in 2021, 10 in 2022, eight in 2023, nine in 2024 and 30 in 2025. The 2025 figure represents an increase of approximately 233 per cent over 2021 and more than three times the number recorded in 2024. A total of 102 persons were arrested in connection with the laboratory-dismantling operations.
The report identifies mephedrone as the most commonly manufactured drug in India’s clandestine laboratories. Recoveries from the multi-drug facilities dismantled in 2025 included 320.376 kg of mephedrone, 225.16 kg of ephedrine, 260.363 kg of pharmaceutical tablets containing psychotropic substances and 34,657 kg of other substances.
The report identifies Maharashtra, Rajasthan and Madhya Pradesh as states where clandestine laboratories are concentrated, pointing towards organised supply chains operating in these regions. It also highlights the risk of diversion of precursor chemicals, particularly ephedrine and pseudoephedrine, into illicit manufacturing.
Importantly, the report observes that the sharp rise in laboratory detections could indicate either a significant expansion of the clandestine manufacturing ecosystem or improved enforcement and detection capabilities, or both.
The emergence of clandestine manufacturing facilities assumes significance against the backdrop of changing drug-trafficking patterns.
Mephedrone, methamphetamine and other synthetic substances are increasingly important components of the illicit drug landscape. The NCB report highlights the need to monitor precursor chemicals that can be diverted from legitimate pharmaceutical and chemical supply chains.
India’s position as a major pharmaceutical producer creates an additional enforcement challenge as traffickers can exploit legitimate commercial channels to obtain chemicals and pharmaceutical substances.
The findings underline the importance of monitoring manufacturers, distributors, chemical suppliers and pharmaceutical supply chains alongside conventional drug seizures.
Darknet, Cryptocurrency And Courier Networks
The report also identifies the growing use of digital platforms and alternative logistics channels by drug-trafficking syndicates.
Between 2021 and 2025, the NCB booked 110 darknet-related cases.
According to the report, trafficking networks are using anonymous vendor accounts, encrypted messaging applications, cryptocurrency and digital wallets to coordinate transactions and conceal identities. International drop-shipping, re-shipping and postal parcel networks are also being used to move illicit consignments.
Courier and postal channels remained significant in 2025, with 174 cases registered and 972 kg of drugs seized. Although the number of cases and quantity seized have declined compared with 2021, the report describes these channels as an important route for drug traffickers.
Eastern Corridor And Maritime Routes
The report also highlights the growing significance of the Golden Triangle, particularly Myanmar, as a source of illicit opiates and synthetic drugs.
Manipur, Mizoram and Nagaland are identified as states facing particularly high exposure because of their proximity to Myanmar-linked trafficking networks. The report describes routes entering through Mizoram’s Champhai region and moving towards Silchar in Assam’s Barak Valley through Aizawl and adjoining road networks, before reaching Meghalaya and Guwahati.
The Andaman and Nicobar Islands are another area of concern, with the report highlighting the exploitation of uninhabited islands for clandestine warehousing and mid-sea drop-offs.
Maritime interdictions during 2025 included seizures of ganja, hashish oil, amphetamine and hashish across coastal regions, including Tamil Nadu and Gujarat.
Enforcement Challenge Is Changing
The findings suggest that India’s narcotics enforcement challenge is no longer limited to conventional cross-border drug smuggling.
Drone-assisted trafficking, domestic synthetic-drug manufacturing, precursor-chemical diversion, darknet marketplaces and cryptocurrency transactions are creating a more complex operational environment.
The sharp rise in drone-related incidents and clandestine laboratory detections underlines the need for stronger technological surveillance, intelligence sharing, precursor monitoring, forensic capabilities and financial investigations.
The NCB’s 2025 report thus highlights a changing narcotics landscape in which enforcement agencies must address both the transportation of illicit drugs and the manufacturing, financing and distribution networks supporting the trade.